4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Atefeh Garzan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States. Hauptthemen laut MEDLINE: Virus Replication, Antiviral Agents, Thiazoles, Amides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
2-(Methylthio)-N-(4-(naphthalen-2-yl)thiazol-2-yl)nicotinamide 1 was identified as an inhibitor against Chikungunya virus (CHIKV) with good antiviral activity [EC50 = 0.6 μM; EC90 = 0.93 μM and viral titer reduction (VTR) of 6.9 logs at 10 μM concentration] with no observed cytotoxicity (CC50 = 132 μM) in normal human dermal fibroblast (NHDF) cells. Structure-activity relationship (SAR) studies to further improve the potency, efficacy, and drug-like properties of 1 led to the discovery of a new potent inhibitor N-(4-(3-((4-cyanophenyl)amino)phenyl)thiazol-2-yl)-2-(methylthio)nicotinamide 26, which showed a VTR of 8.7 logs at 10 μM against CHIKV and an EC90 of 0.45 μM with considerably improved MLM stability (t1/2 = 74 min) as compared to 1. Mechanism of action studies show that 26 inhibits alphavirus replication by blocking subgenomic viral RNA translation and structural protein synthesis. The in vivo efficacy studies of compound 26 on CHIKV infection in mice are reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States.
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, Oregon 97006, United States.
- Department of Immunology and Microbiology, University of Colorado School of Medicine, 12800 E. 19th Avenue, Aurora, Colorado 80045, United States.
- Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States.
ORCID-Profile: S Kaleem Ahmed, Corinne E Augelli-Szafran, Omar Moukha-Chafiq
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Garzan, A., Ahmed, S. K., Haese, N. N., Sulgey, G., Medica, S., Smith, J. L., Zhang, S., Ahmad, F., Karyakarte, S., Rasmussen, L., DeFilippis, V., Tekwani, B., Bostwick, R., Suto, M. J., Hirsch, A. J., Morrison, T. E., Heise, M. T., Augelli-Szafran, C. E., Streblow, D. N., …, & Moukha-Chafiq, O. (2024). 4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01073
Vancouver
Garzan A, Ahmed SK, Haese NN, Sulgey G, Medica S, Smith JL, et al. 4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01073
BibTeX
@article{Garzan2024,
author = {Garzan, Atefeh and Ahmed, S Kaleem and Haese, Nicole N and Sulgey, Gauthami and Medica, Samuel and Smith, Jessica L and Zhang, Sixue and Ahmad, Fahim and Karyakarte, Shuklendu and Rasmussen, Lynn and DeFilippis, Victor and Tekwani, Babu and Bostwick, Robert and Suto, Mark J and Hirsch, Alec J and Morrison, Thomas E and Heise, Mark T and Augelli-Szafran, Corinne E and Streblow, Daniel N and Pathak, Ashish K and Moukha-Chafiq, Omar},
title = {4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01073}
}
EUVIMED